MedWaves Inc. Company Profile
MedWaves, Inc. develops innovative and proprietary microwave ablation technology for minimally invasive and surgical coagulation-ablation therapy of soft tissues and tumors. The Company’s management team has extensive experience in the medical device marketplace. MedWaves’ clinical advisors include renowned interventional radiologists and surgeons from UCSD, St. Joseph, The Cushier Skills Center, Brown University, and University of Pisa. MedWaves, Inc. is a privately held corporation located in San Diego, California, USA.
News from MedWaves Inc.:
MedWaves Announces Doctors at Hospital of Johann Wolfgang Goethe University in Frankfurt, Germany Perform First Successful Treatment of 'Hot and Cold' Thyroid Nodules With Combination of Its AveCure™ Microwave Ablation System and Radioiodine
Unique, non-surgical combination therapy works on both hot and cold thyroid nodules FRANKFURT, Germany, April 9, 2013 /PRNewswire/ — Dr. Hudayi Korkusuz, a radiologist at the Department of Nuclear Medicine, has conducted the first combination treatment of microwave ablation and radiotherapy. (Photo: http://photos.prnewswire.com/prnh/20130409/PH90748 ) Annually in Germany, about 100,000 thyroid operations are performed. In many cases, treatment […]
MedWaves Inc.'s Microwave Ablation Proves Effective in Destroying Thyroid Nodules in German Hospital Patient
Successful treatment of patient at Frankfurt University Hospital shows promise for healing thyroid disease without surgery FRANKFURT, Germany, Nov. 26, 2012 /PRNewswire/ — The Department of Nuclear Medicine at the Frankfurt University Hospital recently became the first European hospital to use microwaves to ablate thyroid nodules. The success of the new treatment comes as great news […]
MedWaves, Incorporated Announces Receipt of Taiwan Food and Drug Administration (TFDA) Certification to Import and Sell Its Patented AveCure™ Microwave Ablation System and Devices
SAN DIEGO, Sept. 21, 2011 — MedWaves' AveCure™ microwave coagulation-ablation (MWA) system uses microwave energy to volumetrically coagulate-ablate (destroy) soft-tissue lesions (abnormal structures) safely, effectively, precisely and with repeatability. The system has successfully treated over 1,000 patients worldwide, including lesions in bone, kidney, liver, lung and pancreas. The Company plans to bring its technology to […]
MedWaves, Incorporated Announces Receipt of the Chinese State Food and Drug Administration (SFDA) Certification to Import and Sell Its Patented AveCure™ Microwave Ablation System and Devices
SAN DIEGO, Sept. 7, 2011 — MedWaves' AveCure™ microwave coagulation-ablation (MWA) system uses microwave energy to volumetrically coagulate-ablate (destroy) soft-tissue lesions (abnormal structures) safely, effectively, precisely and with repeatability. The system has successfully treated over one-thousand patients worldwide, including lesions in bone, kidney, liver, lung and pancreas. The Company plans to bring its technology to […]
MedWaves, Incorporated Announces Receipt of Korean Food and Drug Administration (KFDA) Certification to Import and Sell Its Patented AveCure™ Microwave Ablation System and Devices Through Its Distribution Partner in South Korea
SAN DIEGO, Aug. 31, 2011 — MedWaves' AveCure™ Microwave Coagulation-Ablation (MWA) System uses microwave energy to volumetrically coagulate-ablate (destroy) soft-tissue lesions (abnormal structures) safely, effectively, precisely and with repeatability. The system has successfully treated over one-thousand patients worldwide, including lesions in bone, kidney, liver, lung and pancreas. The Company plans to bring its technology to […]
MedWaves, Inc. Sponsors Investigational Studies to Evaluate Its Patented Microwave Thermal Coagulation-Ablation System for Treatment of Tumors in Liver and Lung
SAN DIEGO, Sept. 18, 2009 — MedWaves, Inc. announces ongoing investigational studies to determine the effectiveness of its microwave ablation system for treating soft tissue lesions, such as tumors, in liver and lung. The studies using MedWaves' AveCure(TM) microwave coagulation-ablation system, which includes a generator and probe/antenna (FDA 510(k) cleared and CE Mark certified), are […]
MedWaves, Inc. Announces Receipt of MDD CE Certification and Additional U.S. FDA 510(k) Clearance to Market Its Patented Microwave Coagulation/Ablation System and Devices
SAN DIEGO, Feb. 2, 2009 — MedWaves, Inc. announces the receipt of Medical Device Directive (MDD) CE Mark Certification. This is in addition to having already received U.S. FDA 510(k) clearance to market the Company's patented Microwave Coagulation/Ablation System for surgical applications. The system and single patient use devices enable surgeons and interventional radiologists to […]
